Ross Bridget A's Form 4 filing
Lemaitre Vascular Inc (LMAT) · filed Aug 13, 2025
- Accession no.
- 0001437749-25-026366
- Filed
- Aug 13, 2025
- Trade date
- Aug 8, 2025
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $235.0K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ross Bridget ACIK 0001698518 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | Common Stock | MOption exerciseAcquired | +2,500 | $37.29 | +$93,225 | 5,416 | Direct | |
| Aug 8, 2025 | Common Stock | SSaleDisposed | −2,500 | $94.00 | −$235,000 | 2,916 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | Common Stock | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.